APA (7th ed.) Citation

O, O., LE, T., MD, E., SG, J., JD, H., CT, B., . . . T, S. (2024). Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications. Clinical epidemiology, 16, 379. https://doi.org/10.2147/CLEP.S458901

Chicago Style (17th ed.) Citation

O, Olawore, Turner LE, Evans MD, Johnson SG, Huling JD, Bramante CT, Buse JB, and Stürmer T. "Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications." Clinical Epidemiology 16 (2024): 379. https://doi.org/10.2147/CLEP.S458901.

MLA (9th ed.) Citation

O, Olawore, et al. "Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications." Clinical Epidemiology, vol. 16, 2024, p. 379, https://doi.org/10.2147/CLEP.S458901.